Centerwatch.com produced an interesting article on the implementation of new strategies to improve drug developer’s access to comparator drugs for clinical testing. The article brings to light the difficulty of obtaining comparator drugs, with the Tufts Center for study of Drug Development Director calling it a formidable challenge. This has led to drug providers embracing a proactive approach on getting the drugs they need. They are able to accomplish this by improving communication between R&D and investing in comparator supply companies to make sure in-house capabilities are up to snuff. To read the complete article click here.